• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Interlace Medical Inc.

U.S. Patent Office nixes Smith & Nephew patents in spat with Hologic

February 7, 2014 By Brad Perriello Leave a Comment

U.S. Patent Office nixes Smith & Nephew patents in spat with Hologic

Filed Under: Legal News, News Well, Patent Infringement, Women's Health Tagged With: Hologic, Interlace Medical Inc., Smith & Nephew

Interlace Medical shareholders sue Hologic

November 26, 2013 By Brad Perriello Leave a Comment

Interlace shareholders sue Hologic

Hologic (NSDQ:HOLX) has already been through its fair share of legal action from its acquisition of Interlace Medical, which it acquired for $125 million in 2011.

Filed Under: Legal News, Mergers & Acquisitions, News Well, Women's Health Tagged With: Hologic, Interlace Medical Inc., Smith & Nephew

Hologic asks court to revisit loss to Smith & Nephew over MyoSure device

October 16, 2013 By Brad Perriello Leave a Comment

Hologic wants to revisit Smith & Nephew loss over MyoSure device
Hologic wants to revisit Smith & Nephew loss over MyoSure device

Filed Under: Legal News, News Well, Patent Infringement, Women's Health Tagged With: Hologic, Interlace Medical Inc., Smith & Nephew

Women’s health: Smith & Nephew win over Hologic stands, damages TBD

June 28, 2013 By Brad Perriello Leave a Comment

Women's health: Smith & Nephew win over Hologic stands, damages TBD
Women's health: Smith & Nephew win over Hologic stands, damages TBD

Filed Under: Gynecological, Legal News, News Well, Patent Infringement, Women's Health Tagged With: Hologic, Interlace Medical Inc., Smith & Nephew

Hologic loses $4M patent suit to Smith & Nephew over Interlace fibroid tech

September 6, 2012 By MassDevice staff Leave a Comment

SNN, Interlace logos

Filed Under: Legal News, News Well, Patent Infringement, Women's Health Tagged With: Hologic, Interlace Medical Inc., Smith & Nephew

Hologic inks $125 million deal for Interlace Medical

January 7, 2011 By MassDevice staff Leave a Comment

HOLX, Interlace logos

Hologic Inc. (NSDQ:HOLX) acquired Interlace Medical Inc. and its minimally invasive fibroid treatment for $125 million, saying it hopes to have Interlace’s MyoSure system on the market early this year.

Filed Under: Business/Financial News, Endoscopic, Gynecological, News Well, Women's Health Tagged With: Hologic, Interlace Medical Inc.

Smith & Nephew names Interlace Medical CTO in patent infringement suit

June 11, 2010 By MassDevice staff Leave a Comment

SNN, Interlace logos

Smith & Nephew Inc. (NYSE:SNN) hit Interlace Medical Inc. with a lawsuit accusing the Framingham, Mass.-based firm of infringing a patent with its MyoSure hysteroscopy device.

Smith & Nephew, which has operations in Andover, Mass., accused Interlace chief technology officer Ronald Adams, an SNN employee from 2002 to 2006, of bringing the technology with him when he jumped ship for then-startup Interlace. The patent covers an arthroscopic surgical instrument designed to cut semi-rigid tissue.

Filed Under: Business/Financial News, Endoscopic, Legal News, News Well Tagged With: Interlace Medical Inc., Smith & Nephew

Interlace launches MyoSure trial

March 30, 2010 By MassDevice staff Leave a Comment

Interlace Medical logo

Interlace Medical Inc. launched a clinical trial of its MyoSure fibroid surgery device, aiming to prove that women experience little pain or discomfort during the procedure.

The Framingham, Mass.-based firm’s myomectomy system is a minimally invasive technique that allows for the removal of submucosal fibroids and polyps in a single, out-patient procedure. Submucosal fibroids are benign tumors that grow just beneath the endometrial lining of the uterus.

Filed Under: Business/Financial News, Gynecological, News Well Tagged With: Interlace Medical Inc.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS